SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Biotech Jim7/18/2013 10:43:54 PM
  Read Replies (2) of 23519
 
Looks like VVUS and First Manhattan are coming to an agreement, finally. VVUS is up to the low 15s in after hours. First Manhattan will control the BOD and will sell the company within a year in my view, between 20 and 30 a share. Sales of Qsymia will start to ramp pretty soon due to retail pharmacies now selling the drug combo.

reuters.com

First Manhattan holds 9.9% of the outstanding shares of the approx 100M shares. I hold a bunch, but they don't get to even 0.002%.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext